Abstract:Essentials Corn Trypsin Inhibitor (CTI) is a selective inhibitor of coagulation Factor XII (FXII). Molecular modelling of the CTI-FXIIa complex suggested a canonical inhibitor binding mode. Mutagenesis revealed the CTI inhibitory loop and helices α1 and α2 mediate the interaction. This confirms that CTI inhibits FXII in canonical fashion and validates the molecular model.SUMMARY: Background Corn trypsin inhibitor (CTI) has selectivity for the serine proteases coagulation factor XII and trypsin. CTI is in widespread use as a reagent that specifically inhibits the intrinsic pathway of blood coagulation but not the extrinsic pathway. Objectives To investigate the molecular basis of FXII inhibition by CTI. Methods We performed molecular docking of CTI, using its known crystal structure, with a model of the activated FXII (FXIIa) protease domain. The interaction model was verified by use of a panel of recombinant CTI variants tested for their ability to inhibit FXIIa enzymatic activity in a substrate cleavage assay. Results The docking predicted that: (i) the CTI central inhibitory loop P1 Arg34 side chain forms a salt bridge with the FXIIa S1 pocket Asp189 side chain; (ii) Trp22 from CTI helix α1 interacts with the FXIIa S3 pocket; and (iii) Arg43 from CTI helix α2 forms a salt bridge with FXIIa H1 pocket Asp60A. CTI amino acid substitution R34A negated all inhibitory activity, whereas the G32W, L35A, W22A and R42A/R43A substitutions reduced activity by large degrees of 108-fold, 41-fold, 158-fold, and 100-fold, respectively; the R27A, W37A, W39A and R42A substitutions had no effect. Synthetic peptides spanning CTI residues 20-44 had inhibitory activity that was three-fold to 4000-fold less than that of full-length CTI. Conclusions The data confirm the validity of a canonical model of the FXIIa-CTI interaction, with helix α1 (Trp22), central inhibitory loop (Arg34) and helix α2 (Arg43) of CTI being required for effective binding by contacting the S1, S3 and H1 pockets of FXIIa, respectively.

Molecular Insight into the Inhibition Mechanism of Cyrtominetin to Α-Hemolysin by Molecular Dynamics Simulation.

Direct Visualization of the Dynamic Process of Epsilon Toxin on Hemolysis

Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

Molecular Modeling Reveals the Novel Inhibition Mechanism and Binding Mode of Three Natural Compounds to Staphylococcal Α-Hemolysin

Investigation of the inhibition effect and mechanism of myricetin to Suilysin by molecular modeling

Inhibitor binding and disruption of coupled motions in MmpL3 protein: Unraveling the mechanism of trehalose monomycolate transport

Insights into the structure-affinity relationships and solvation effects between OfHex1 and inhibitors using molecular dynamics simulations

Computational Study on the Inhibition Mechanism of a Cyclic Peptide MaD5 to PfMATE: Insight from Molecular Dynamics Simulation, Free Energy Calculation and Dynamical Network Analysis

Inhibition of Alpha-Hemolysis toxin of Staphylococcus Aureus through Molecular docking simulations

Structural insights into context-dependent inhibitory mechanisms of chloramphenicol in cells

Assembly of a Multivalent Aptamer for Efficient Inhibition of Thermostable Direct Hemolysin Toxicity Induced by Vibrio Parahaemolyticus

Novel inhibitor discovery and the conformational analysis of inhibitors of listeriolysin O via protein-ligand modeling

Molecular Insight into Chymotrypsin Inhibitor 2 Resisting Proteolytic Degradation

Functional expression of a thrombin exosite I inhibitor triabin in Escherichia coli and elucidation of the role of key residues in its inhibitory activity

Mechanistic Insights into the Inhibition of a Common CTLA-4 Gene Mutation in the Cytoplasmic Domain

Interaction of the Minocycline with Extracelluar Protein and Intracellular Protein by Multi-Spectral Techniques and Molecular Docking

Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex

Membrane binding of pore-forming γ-hemolysin components studied at different lipid compositions

Inhibition of Myristic Acid on Suilysin and the Molecular Mechanism

Assessment of the protein interaction between coagulation factor XII and corn trypsin inhibitor by molecular docking and biochemical validation

Conformational Dynamics of the Helix 10 Region As an Allosteric Site in Class A Β-Lactamase Inhibitory Binding.